Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lingxian Granules
- Development stage
- Phase 2
- Lead developer
- Suzhou Youseen New Drug R&D
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lingxian Granules (YS-001) is a standardized Traditional Chinese Medicine (TCM) drug candidate developed by Suzhou Yusen New Drug Development for the treatment of acute gouty arthritis. The drug is a purified extract derived from the root and rhizome of *Clematis chinensis* (Wei Ling Xian), a botanical traditionally utilized for its analgesic and anti-inflammatory properties. Lingxian Granules works by inhibiting the production and activity of key pro-inflammatory mediators, including Interleukin-1 beta (IL-1β) and Tumor Necrosis Factor-alpha (TNF-α), which are central to the inflammatory cascade in gout flares. It has undergone Phase II and Phase III clinical evaluation in China, demonstrating efficacy in reducing joint pain and swelling while maintaining a favorable safety profile.
- Other names
- Lingxian KeliYS-001YS001YS 001
02
Targets
IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Lingxian Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lingxian Granules.